Skip to main content
. 2011 Jun;18(6):940–946. doi: 10.1128/CVI.00020-11

Table 1.

Baselinea study population characteristics among HIV seroconverters

Factorb Value for BMI groupc
P valued
Total cohort Underweight Normal Overweight Obese
BMI, kg/m2 25.2 (3.5) 17.4 (1.1) 22.6 (1.6) 26.9 (1.4) 32.6 (2.1)
Demographics
    Age, yr 28.9 (6.8) 24.7 (4.4) 27.9 (6.7) 29.9 (6.9) 31.0 (6.8) <0.001
    No. (%) male 1,053 (96) 9 (69) 522 (96) 434 (97) 88 (95) <0.001
    Ethnicity [no. (%)] 0.02
        White/non-Hispanic 487 (44) 7 (54) 264 (49) 186 (42) 30 (32)
        African American 439 (40) 5 (38) 207 (38) 182 (41) 45 (48)
        Hispanic/Latino 107 (10) 1 (8) 37 (7) 56 (12) 13 (14)
        Other 64 (6) 0 (0) 35 (6) 24 (5) 5 (5)
HIV-related factors
    Seroconversion window, yr 1.3 (0.7) 1.2 (0.8) 1.3 (0.7) 1.3 (0.7) 1.4 (0.7) 0.83
    No. (%) with HIV diagnosis in HAART era 700 (64) 7 (54) 308 (57) 309 (69) 76 (82) <0.001
    Baseline HIV-RNA, copies/ml [no. (%)] <0.001
        Missing 229 (21) 3 (1) 143 (26) 75 (17) 8 (9)
        <1,000 88 (8) 1 (8) 36 (7) 42 (9) 9 (10)
        1,000-10,000 200 (18) 0 (0.0) 89 (16) 91 (20) 20 (22)
        10,000-100,000 435 (40) 6 (46) 194 (36) 185 (41) 50 (54)
        ≥100,000 145 (13) 3 (23) 81 (15) 55 (12) 6 (6)
    Time to first CD4 count, days 37.1 (25.9) 23.5 (18.9) 37.2 (27.3) 37.2 (24.9) 37.6 (23.1) 0.30
    No. of immune cell counts available (out of 8), median (IQRe) 7 (7-7) 7 (7-7) 7 (7-7) 7 (7-7) 7 (7-7)
a

Baseline is within −30 to +183 days of the documented HIV-positive date.

b

Values are represented as mean (standard deviation) for continuous values and number (percentages) for categorical variables unless otherwise stated.

c

Cohort sizes were as follows: total, n = 1,097; underweight, n = 13; normal, n = 543; overweight, n = 448; obese, n = 93.

d

P value calculated from analysis of variance for continuous variables or chi-square test for categorical variables.

e

IQR, interquartile range.